The trial is a multi-centre, open-label Phase 2 clinical trial testing the safety and efficacy of Acoustic Cluster Therapy (ACT ®) in combination with standard of care (modified FOLFIRINOX ...

A recent study from Simple Divorce has uncovered a compelling connection between financial stress and increasing divorce ...

Camfil, a global leader in clean air solutions, shares its tailored solutions designed specifically to address critical ...

In 2025, the conversation around weight management has evolved far beyond calorie counting and cardio routines. An emerging ...

Stacey Rusch is an entrepreneur, philanthropist, and personality. With a career spanning media, she turned to star on Bravo’s ...

Bioma Probiotics In a bold move to reshape the way people think about gut health and overall wellness, Bioma, a leading-edge ...

The Phase 2 randomized, double-blind, placebo-controlled clinical trial was conducted by Vincentage to investigate the ...

Fueled by a 198% surge in Q4 device sales revenue and a 200% increase in shipments, Hapbee’s revitalized marketing strategy, expanded retail footprint, luxury spa partnerships, and high-profile Board ...

Onco360 is grateful for the opportunity to partner with the team at Deciphera and become a specialty pharmacy provider for ROMVIMZA,” said Benito Fernandez, Chief Commercial Officer. “This addition ...

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) and The Hospital for Sick Children (SickKids) are pleased to announce that SickKids employees will become ...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend ...

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding ...